Hercules Capital Inc (N:HTGC)

May 10, 2022 06:00 am ET
Hercules Capital Receives BBB- Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. (“Fitch”) has assigned Hercules a
May 09, 2022 06:00 am ET
Hercules Capital Announces Date of 2022 Annual Meeting of Stockholders
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct its 2022 Annual Meeting of Stockholders by virtual meeting on Thursday, June 23, 2022 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was mailed separately on or about May 4, 2022 to shareholders of record as of April 25, 2022.
May 05, 2022 04:10 pm ET
Hercules Capital Reports First Quarter 2022 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31
May 03, 2022 06:03 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the First Quarter of 2022
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
May 03, 2022 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.33 per Share for the First Quarter of 2022
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a first qua
Apr 18, 2022 06:00 am ET
Hercules Receives a BBB Reaffirmed Investment Grade Corporate Rating From DBRS, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that DBRS, Inc. (“DBRS Morningstar”) has reaffirmed Hercul
Apr 14, 2022 06:00 am ET
Hercules Capital Announces Date for Release of First Quarter 2022 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2022 financial res
Apr 04, 2022 04:05 pm ET
Viridian Therapeutics Secures Flexible Credit Facility for Up to $75 Million From Hercules Capital
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, today announced that the Company has entered into a debt financing agreement...
Mar 01, 2022 06:00 am ET
Hercules Capital Announces Upcoming Event for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be part
Feb 22, 2022 04:10 pm ET
Hercules Capital Reports Fourth Quarter and Full-Year 2021 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year
Feb 22, 2022 06:02 am ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.60 per Share
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a new supp
Feb 22, 2022 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.33 per Share for the Fourth Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth qu
Feb 08, 2022 07:00 am ET
Lucira Health Secures Debt Facility of Up to $80 Million from Hercules Capital and Silicon Valley Bank
Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on February 4, 2022,...
Feb 08, 2022 06:00 am ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2021 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 202
Feb 02, 2022 07:00 am ET
Tarsus Completes Enrollment for the Pivotal Phase 3 Saturn-2 Trial of TP-03 to Treat Demodex Blepharitis and Secures $175 Million Credit Facility
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced it has completed enrollment of...
Feb 01, 2022 06:00 am ET
Hercules Capital Enhances C-Suite for Future Growth
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced two internal promotions and one new addition to the execut
Jan 20, 2022 10:35 am ET
Hercules Capital Closes Upsized Public Offering of $350.0 Million 3.375% Notes Due 2027
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has closed an underwritten public offering of $350.0 million in aggregate principal amount of 3.375% notes due January 2027 (the “Notes”).
Jan 14, 2022 05:33 pm ET
Hercules Capital Prices Upsized Public Offering of $350.0 Million 3.375% Notes due 2027
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has priced an underwritten public offering of $350.0 million in aggregate principal amount of 3.375% notes due January 2027 (the “Notes”). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered a
Jan 04, 2022 07:30 am ET
TG Therapeutics Expands Term Loan Facility With Hercules Capital to $200 Million
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that its existing term loan facility agreement with Hercules Capital, Inc. (NYSE: HTGC), has been amended to increase the size of the facility to $200 million, with $70 million funded at...
Nov 29, 2021 06:00 am ET
Hercules Capital Surpasses $2.0 Billion in Annual Gross Debt and Equity Commitments for First Time in History
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it, together with external funds managed by its advis
Nov 10, 2021 06:00 am ET
Hercules Capital Further Strengthens Its Capital Resources With New $100.0 Million Multi-Currency Credit Facility
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that effective November 9, 2021, it has entered into a new
Nov 09, 2021 04:10 pm ET
Hercules Capital Announces Upcoming Events for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be part
Oct 28, 2021 04:10 pm ET
Hercules Capital Reports Third Quarter 2021 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended Septembe
Oct 26, 2021 06:03 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.07 per Share for the Third Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Oct 26, 2021 06:00 am ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.33 per Share for the Third Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increased and declar
Oct 20, 2021 06:00 am ET
Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of Directors
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Pam Randhawa was appointed to serve as a member of it
Oct 19, 2021 07:30 am ET
Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital
Locus Biosciences, Inc. (“Locus”), a clinical-stage biotechnology company developing a new class of precision engineered bacteriophage treatments for a diverse set of bacterial and inflammatory diseases, today announced that the company has entered...
Oct 14, 2021 06:00 am ET
Hercules Capital Announces Date for Release of Third Quarter 2021 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2021 financial res
Oct 05, 2021 08:00 am ET
Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital
Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced that the company has entered into a debt facility of up to $30.0 million with Hercules Capital, Inc. (NYSE: HTGC), a specialty financing lender for life science and technology companies....
Sep 27, 2021 08:00 am ET
Corium Secures $235 Million in Debt Financing
BOSTON, Sept. 27, 2021 /PRNewswire/ -- Corium, Inc. (Corium), a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, today announces that it has closed on a $235 million term loan agreement with Hercules Capital, Inc. (NYSE: HTGC), a leader in specialty financing for life science and technology companies. Corium will receive an initial tranche of $100 million, and the remaining funds will be available in three additional tranches upon the achievement of certain pre-defined milestones. 
Sep 27, 2021 06:00 am ET
Hercules Capital Delivers a New Record by Surpassing $1.5 Billion of Annual Gross Debt and Equity Commitments
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it, together with external funds managed by its advis
Sep 20, 2021 08:00 am ET
Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from Hercules Capital
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today reported it has obtained a $200 million term loan facility...
Sep 16, 2021 04:10 pm ET
Hercules Capital Closes Public Offering of $325.0 Million 2.625% Notes due 2026
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has closed an underwritten public offering of $325.0 million in aggregate principal amount of 2.625% notes due 2026 (the “Notes”).
Sep 13, 2021 04:41 pm ET
Hercules Capital Prices Public Offering of $325.0 Million 2.625% Notes Due 2026
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has priced an underwritten public offering of $325.0 million in aggregate principal amount of 2.625% notes due September 2026 (the “Notes”). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered
Aug 25, 2021 08:00 am ET
Better Therapeutics Secures $50 Million Debt Facility From Hercules Capital
Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it has secured a loan facility for up to $50 million from Hercules Capital, Inc. (NYSE: HTGC).
Aug 16, 2021 06:30 am ET
BiomX Reports Second Quarter 2021 Financial Results and Provides Business Update
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage cocktails that target specific pathogenic bacteria, today reported financial results and provided a...
Aug 02, 2021 06:00 am ET
Hercules Capital Reaches $1.0 Billion Milestone in Annual Debt and Equity Commitments for the Fourth Consecutive Year
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has originated more than $1.0 billion year-to-date
Jul 29, 2021 04:10 pm ET
Hercules Capital Reports Second Quarter 2021 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30
Jul 27, 2021 06:01 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.07 Per Share for the Second Quarter Of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Jul 27, 2021 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Second Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a second qu
Jul 15, 2021 06:00 am ET
Hercules Capital Announces Date for Release of Second Quarter 2021 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2021 financial re
Jun 25, 2021 01:23 pm ET
Hercules Capital Announces the Appointment of Wade Loo to Its Board of Directors
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that effective July 1, 2021, Wade Loo was appointed to the
Jun 08, 2021 06:00 am ET
Hercules Capital Announces Date of 2021 Annual Meeting of Stockholders
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct its 2021 Annual Meeting of Stockholders by virtual meeting on Thursday, June 24, 2021 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was mailed separately on or about April 30, 2021 to shareholders of record as of April 23, 2021.
Jun 03, 2021 07:01 am ET
Nabriva Agrees to Extension of Principal Debt Repayments Under Existing Loan Agreement with Hercules Capital
Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it has reached an agreement with Hercules...
May 28, 2021 01:05 pm ET
Hercules Capital Announces Its Intention to Fully Redeem its 5.25% Notes due 2025
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its intent to fully redeem approximately $75.0 million (face v
May 19, 2021 08:00 am ET
HiberCell Closes $67.4 Million Series B Financing and Secures $30 Million Debt Facility from Hercules Capital
HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, today announced that it has completed a Series B financing round for gross proceeds of $67.4 million.   Concurrent to this financing,...
May 14, 2021 08:30 am ET
SCYNEXIS Secures Term Loan Facility for up to $60 Million with Hercules Capital and Silicon Valley Bank
SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported that it has secured a $60 million term loan facility with Hercules...
May 13, 2021 04:03 pm ET
AGTC Announces Expansion of Manufacturing and Analytics Capabilities to Advance Commercialization of Gene Therapy Product Candidates
Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that it has initiated plans...
Apr 29, 2021 04:10 pm ET
Hercules Capital Reports First Quarter 2021 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31
Apr 27, 2021 06:03 am ET
Hercules Capital Announces Fiscal 2021 Supplemental Cash Distribution of $0.28 Per Share
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Apr 27, 2021 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the First Quarter of 2021
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a first qua
Apr 15, 2021 06:00 am ET
Hercules Capital Announces Date for Release of First Quarter 2021 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2021 financial res
Mar 25, 2021 06:00 am ET
Hercules Adviser LLC Announces the Closing of Its Inaugural Institutional Private Credit Fund
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced that Hercules Adviser LLC (“Hercules Adviser”), a wholly-owned subsidiary of Hercules Capital, has successfully closed its inaugural institutional private credit fund.
Mar 08, 2021 06:00 am ET
Hercules Capital Receives Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors Service
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Moody’s Investors Service, Inc. (“Moody’s”) has assig
Mar 04, 2021 04:21 pm ET
Hercules Capital Completes Investment Grade Bond Offering of $50.0 Million of 4.55% Notes due March 2026
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced the completed issuance of a private offering in aggregate principal amount of $50.0 million 4.55% Notes due March 2026 (the “March B Notes”). On November 4, 2020, the Company completed the initial issuance of $50.0 million 4.50% Notes due March 4, 2026, which were initially assigned a BBB+ rating by Kroll Bond Rating Agency.
Mar 02, 2021 06:00 am ET
Hercules Capital Announces Upcoming Event for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be virt
Feb 23, 2021 04:10 pm ET
Hercules Capital Reports Fourth Quarter and Full-Year 2020 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year
Feb 22, 2021 06:02 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.05 per Share for the Fourth Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Feb 22, 2021 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Fourth Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth qu
Feb 09, 2021 06:00 am ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2020 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 202
Jan 19, 2021 10:00 am ET
Rapid Growth and Trailblazing Tech in 2020 Positions CloudBolt Software to Redefine Cloud Management in 2021
CloudBolt Software, the enterprise cloud management leader, solidified its position as the intelligent choice for cloud management in 2020. With significant growth and global expansion, two acquisitions, and game-changing innovation, CloudBolt’s...
Nov 18, 2020 10:00 am ET
CloudBolt Announces $35 Million in Series B Funding Led by Insight Partners
CloudBolt Software, the enterprise leader in cloud management and integration solutions, today announced $35M in series B funding, consisting of both equity and venture debt. The equity was led by Insight Partners, a global venture capital and...
Nov 04, 2020 05:03 pm ET
Hercules Capital Announces an Investment Grade Bond Offering Totaling $100.0 Million Due 2026
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced a private offering totaling $100.0 million in aggregate principal amount of $50.0 million 4.50% Notes due March 2026 (the “November Notes”) and $50.0 million 4.55% Notes due March 2026 (the “March Notes”).
Nov 03, 2020 10:57 am ET
Udacity Drives 120% Enterprise and Government Growth in Q3, Secures $75 Million to Continue Momentum
MOUNTAIN VIEW, Calif., Nov. 3, 2020 /PRNewswire/ -- Udacity, which prepares employees and students for careers of the future, today announced its Q3 enterprise and government bookings rose by 120% year-over-year, total bookings increased 80% year-over-year, and ARR increased 260% in H1 2020.  In addition, the company has reached profitability and, to continue building on this growth, Udacity has signed a $75 million debt facility, with Hercules Capital (NYSE: HTGC) serving as the underwriter.
Oct 29, 2020 04:10 pm ET
Hercules Capital Reports Third Quarter 2020 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended Septembe
Oct 28, 2020 04:10 pm ET
Hercules Capital Gains Additional Liquidity for New Investments with Approval of Third SBA License
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced it received agency committee approval by the U.S. Small Bu
Oct 27, 2020 06:02 am ET
Hercules Capital Announces Supplemental Cash Distribution of $0.02 per Share for the Third Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Oct 27, 2020 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Third Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a third qua
Oct 22, 2020 06:00 am ET
Hercules Capital Announces Date for Release of Third Quarter 2020 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2020 financial res
Oct 01, 2020 04:30 pm ET
Geron Secures Loan Facility for Up to $75 Million
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has entered into a loan facility for up to $75 million with Hercules Capital, Inc. (NYSE: HTGC) and Silicon Valley Bank (SVB). The loan facility provides the Company with access to non-dilutive financial resources to support the imetelstat development program, as well as working capital and general corporate purposes.
Sep 29, 2020 07:00 am ET
Axsome Therapeutics Announces $225 Million Term Loan Facility with Hercules Capital
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, has secured a $225 million term loan facility with Hercules Capital, Inc. (NYSE: HTGC)....
Aug 04, 2020 04:05 pm ET
UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital
UNITY Biotechnology (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that it has entered into a $80 million debt facility with Hercules...
Jul 30, 2020 04:10 pm ET
Hercules Capital Reports Second Quarter 2020 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30
Jul 29, 2020 06:00 am ET
Hercules Capital Surpasses $1.0 Billion in Cumulative Distributions to Shareholders since IPO
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that its Board of Directors has declared a second quarter 2
Jul 22, 2020 04:10 pm ET
Hercules Capital Announces Date for Release of Second Quarter 2020 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2020 financial re
Jun 09, 2020 07:30 am ET
Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022
Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced it has agreed to terms with Hercules Capital, Inc. (NYSE: HTGC) on a debt facility to provide up to...
Jun 08, 2020 06:00 am ET
Hercules Capital Receives SBA “Green Light” Letter Approval to Complete Its Third SBIC License
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that the U.S. Small Business Administration (“SBA”) has iss
Jun 03, 2020 04:10 pm ET
Hercules Capital Completes 5-Year Investment Grade Bond Offering of $70.0 Million of 4.31% Notes due June 2025
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced the completed issuance of a private offering in aggregate principal amount of $70.0 million 4.31% Notes due June 2025 (the “June Notes”). On February 5, 2020, the Company completed the initial issuance of $50.0 million 4.28% Notes due February 2025, which were initially assigned a BBB+ rating by Kroll Bond Rating Agency.
Jun 01, 2020 04:01 pm ET
G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital
G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company has entered into a debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $100 million. G1 plans to use the proceeds to...
May 04, 2020 04:10 pm ET
Hercules Capital Reports First Quarter 2020 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31
May 01, 2020 06:00 am ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the First Quarter of 2020
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Direc
Apr 27, 2020 06:00 am ET
Hercules Capital Announces Date of 2020 Annual Meeting of Stockholders and Special Meeting of Stockholders
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct both its 2020 Annual Meeting of Stockholders and its Special Meeting of Stockholders by virtual meeting on Friday, June 12, 2020 at 9:00 a.m. and 10:00 a.m. (Pacific Time), respectively. The proxy statement for each meeting will be mailed separately on or about April
Apr 16, 2020 06:00 am ET
Hercules Capital Announces Date for Release of First Quarter 2020 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2020 financial res
Mar 23, 2020 06:00 am ET
Hercules Capital Business and Coronavirus Update
The team at Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) is working collectively with our employees, shareholders, stakeholders, bondholders, rating agencies, portfolio companies, and our venture capital and private equity sponsors to navigate the significant challenges created by the unprecedented COVID-19 (Coronavirus) pand
Feb 20, 2020 04:10 pm ET
Hercules Capital Reports Fourth Quarter and Record Full-Year 2019 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year
Feb 20, 2020 06:00 am ET
Hercules Capital Strengthens Its Capital Resources with New $400.0 Million Credit Facility to Support Continued Investment Portfolio Growth
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that effective February 20, 2020, it has replaced its existi
Feb 19, 2020 04:12 pm ET
Hercules Capital Announces Supplemental Cash Distribution of $0.08 per Share for the Fourth Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a suppleme
Feb 19, 2020 04:10 pm ET
Hercules Capital Declares Distribution of $0.32 per Share for the Fourth Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth qu
Feb 06, 2020 06:00 am ET
Hercules Capital Announces 5-Year Investment Grade Bond Offering Totaling $120.0 Million
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced a private offering totaling $120.0 million in aggregate principal amount of $50.0 million 4.28% Notes due February 2025 (the “February Notes”) and $70.0 million 4.31% Notes due June 2025 (the “June Notes”).
Jan 30, 2020 06:00 am ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2019 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fou
Jan 14, 2020 06:00 am ET
Hercules Capital Reaches $10.0 Billion Milestone in Total Debt Commitments Since Inception
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has originated more than $10.0 billion in total de
Jan 09, 2020 08:30 am ET
ChemoCentryx Announces Credit Facility of Up to $100 Million with Hercules Capital
ChemoCentryx, Inc., (NASDAQ: CCXI) today announced that the Company has secured a credit facility of up to $100 million provided by Hercules Capital, Inc. (NYSE: HTGC), a leader in customized financing for companies in life sciences and...
Jan 08, 2020 06:00 am ET
Hercules Capital Highlights 2019 Achievements, Setting a New Investment Record with $1.47 Billion in Total New Debt and Equity Commitments
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest specialty financing provider to innovative venture, growth and established stage companies backed by top-tier venture capital and select private equity firms, today announced select investment milestones and operating highlights for 2019.
Dec 30, 2019 08:30 am ET
Myovant Sciences Announces Closing of $400 Million Loan Facility, Repayment of Debt, Board of Director Transitions, and Executive Promotions
Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer, today announced the closing of the previously announced landmark, low-interest (3-month LIBOR plus 3%) loan...
Oct 30, 2019 04:10 pm ET
Hercules Capital Reports Third Quarter 2019 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter
Oct 29, 2019 04:11 pm ET
Hercules Capital Announces Supplemental Cash Distribution of $0.03 per Share for the Third Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has decla
Oct 29, 2019 04:10 pm ET
Hercules Capital Declares Distribution of $0.32 per Share for the Third Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declar
Oct 09, 2019 06:00 am ET
Hercules Announces Date for Release of Third Quarter 2019 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2019 financial result
Sep 18, 2019 06:00 am ET
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. (“KBRA”) has reaffirmed H
Sep 17, 2019 06:00 am ET
Hercules Capital to Discuss Venture Lending Opportunities at the Upcoming Events for the Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be particip
Aug 01, 2019 04:12 pm ET
Hercules Capital Announces Supplemental Cash Distribution of $0.02 per Share for the Second Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a supplementa
Aug 01, 2019 04:11 pm ET
Hercules Capital Declares Distribution of $0.32 per Share for the Second Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a second quart
Aug 01, 2019 04:10 pm ET
Hercules Capital Reports Second Quarter 2019 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30, 2
Jul 18, 2019 06:00 am ET
Hercules Capital Appoints Scott Bluestein as Chief Executive Officer and President
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or “the Company”) today announced that its board of directors has appointed Scott Bluestein as Chief Executive Officer and President, effective immediately. Mr. Bluestein, who has held several leadership roles in his nine years with the Company, has served as Hercules’ interim CEO since March 2019 and as Chief Inv
Jul 16, 2019 04:10 pm ET
Hercules Capital Completes Investment Grade Bond Offering of $105.0 Million of 4.77% Notes Due 2024
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced that it has closed a private offering of $105.0 million aggregate principal amount of 4.77% notes due 2024 (the “Notes”).
Jul 11, 2019 06:00 am ET
Hercules Announces Date for Release of Second Quarter 2019 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital and select private equity firms, today announced that it has scheduled its second quarter 2019 financial results conference call for
Jul 01, 2019 06:00 am ET
Hercules Receives a BBB Reaffirmed Investment Grade Corporate Rating from DBRS
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that DBRS, Inc. (“DBRS”) has reaffirmed Hercules’ investment grade corporate rating of BBB
Jun 27, 2019 07:00 am ET
Antares Pharma Announces Amendment to Existing Loan and Security Agreement With Hercules Capital
Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares” or “the Company”) today announced that it has entered into an amendment to its existing loan and security agreement with Hercules Capital, Inc. (NYSE: HTGC), (“Hercules”), to increase the available...
Jun 25, 2019 06:00 am ET
Hercules Capital Announces Multiple Portfolio Company Achievements in Q2 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading U.S. and top tier venture capital and select private equity firms, today announced some of the latest achievements for select portfolio com
Jun 17, 2019 04:10 pm ET
Hercules Capital, Inc. Closes Public Offering of Common Stock Including Option to Purchase Additional Shares
Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company") today announced that it has closed its underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $12.64 per share. In addition, the underwriters fully exercised their over-allotment option to purchase 750,000 additional shares of Hercules’ common stock. Today’s closing included the sale of the over-allotment shares, bringing the total number of shares sold in this offering to 5,750,000. The underwriters purchased the shares of common stock
Jun 13, 2019 06:00 am ET
Hercules Capital, Inc. Prices Public Offering of Common Stock
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) today announced that it has priced its public offering of 5,000,000 shares of its common stock at a public offering price of $12.64 per share for total gross proceeds of approximately $63.2 million. Hercules has also granted the underwriters an option to purchase up to an additional 750,000 shares of its common stock. The offering is subject to customary closing conditions and is expected to close on June 17, 2019. Morgan Stanley, Wells Fargo Securities, and Keefe, Bruyette & Woods, A St
Jun 12, 2019 04:29 pm ET
Hercules Capital, Inc. Announces Public Offering of Common Stock
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) today announced that it plans to make a public offering of 5,000,000 shares of its common stock. Hercules also plans to grant the underwriters for the offering an option to purchase up to an additional 750,000 shares of its common stock. Morgan Stanley, Wells Fargo Securities, and Keefe, Bruyette & Woods, A Stifel Company, are acting as joint book-running managers in this offering, and Compass Point and Wedbush Securities are acting as co-managers in this offering.
May 15, 2019 06:00 am ET
Hercules Capital to Discuss 2019 Growth Opportunities at the B. Riley FBR Institutional Investor Conference
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be
May 07, 2019 06:00 am ET
Hercules Capital Appoints Two Senior Investment Professionals in New Leadership Roles
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest specialty financing provider to innovative venture growth stage companies backed by leading venture capital and private equity firms, today announced the promotions of R. Bryan Jadot to Head of Life Sciences Venture Lending and Steve Kuo to Head o
May 02, 2019 04:14 pm ET
Hercules Capital Announces Supplemental Cash Distribution of $0.01 per Share for the First Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a sup
May 02, 2019 04:12 pm ET
Hercules Capital Increases its Quarterly Distribution to $0.32 per Share for the First Quarter of 2019
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increased and d
May 02, 2019 04:10 pm ET
Hercules Capital Reports First Quarter 2019 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended Mar
Apr 11, 2019 06:00 am ET
Hercules Announces Date for Release of First Quarter 2019 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital and select private equity firms, today announced that it has scheduled its first quarter 2019 financial results conference c
Mar 13, 2019 06:00 am ET
Hercules Capital Appoints Robert Badavas as Interim Chairman and Scott Bluestein as Interim Chief Executive Officer
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or “the Company”) today announced that effective immediately, Manuel Henriquez has voluntarily stepped aside as Chairman and Chief Executive Officer. The Board has elected Robert P. Badavas, currently Lead Independent Director to be Interim Chairman of the Board and elected Sco
Mar 04, 2019 06:00 am ET
Hercules Capital Named 2018 Specialty Finance Lender of the Year, Americas by Private Debt Investor
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading U.S. and top-tier venture capital and select private equity firms, was named 2018 Specialty Finance Lender of the Year, Americas by
Feb 28, 2019 04:01 pm ET
TG Therapeutics Announces Proposed Public Offering of Common Stock and Closing of $60.0 Million Venture Debt Financing
TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public...
Feb 27, 2019 06:00 am ET
Hercules to Discuss 2019 Growth Opportunities at RBC Financial Institutions Conference
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading U.S. and top-tier venture capital and select private equity firms, today announced that members of the executive management team wil
Feb 26, 2019 07:35 am ET
Analysis: Positioning to Benefit within Canopy Growth, Procter & Gamble, Hercules Capital, On Deck Capital, Ball, and Sun Life Financial — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy Growth Corporation (NYSE:CGC), Procter & Gamble Company (NYSE:PG),...
Feb 21, 2019 04:15 pm ET
Hercules Capital Announces its 54th Consecutive Quarterly Distribution of $0.31 per Share for the Fourth Quarter of 2018
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading U.S. and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a
Feb 21, 2019 04:10 pm ET
Hercules Capital Reports Record Fourth Quarter and Full-Year 2018 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year ended December 31,
Feb 21, 2019 06:00 am ET
Hercules Capital Appoints Seth Meyer as Chief Financial Officer
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading U.S. and top-tier venture capital and select private equity firms, today announced the appointment of Seth Meyer as Chief Financial
Feb 20, 2019 05:55 pm ET
Hercules Capital Increases and Strengthens Its Capital Resources with New $200.0 Million Credit Facility to Support Continued Investment Portfolio Growth and Expansion Strategy
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading U.S. and top-tier venture capital and select private equity firms, today announced that effective February 20, 2019, it has replaced
Feb 18, 2019 02:00 am ET
Motif BioSciences Enters into Amendment Agreement with Hercules Capital
Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that Motif BioSciences Inc. (a wholly owned subsidiary) has entered into an amendment agreement with its...
Feb 12, 2019 06:00 am ET
Hercules Capital Announces Multiple Outstanding Achievements by Numerous Investment Portfolio Companies
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading U.S. and top tier venture capital and select private equity firms, today announced some of the latest achievements for the followin
Feb 05, 2019 06:00 am ET
Hercules Capital Expands Board of Directors to Nine Members with the Appointment of Gayle Crowell
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading and top-tier venture capital firms, today announced the appointment of Gayle Crowell to serve as a member of its board of directors, effecti
Jan 31, 2019 06:00 am ET
Hercules Announces Date for Release of Fourth Quarter and Full-Year 2018 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2018 financial resul
Jan 25, 2019 08:10 am ET
Investor Expectations to Drive Momentum within Hercules Capital, Alexandria Real Estate Equities, Ironwood Pharmaceuticals, 22nd Century Group, BorgWarner, and Forestar Group — Discovering Underlying
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Hercules Capital, Inc. (NYSE:HTGC), Alexandria Real Estate Equities,...
Jan 22, 2019 01:42 pm ET
Hercules Capital Completes $250.0 Million Securitization to Support Continued Growth
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced that Hercules Capital Funding Trust 2019-1, a newly-formed wholly owned, indirect subsidiary of Hercules, has issued $250.0 million of class A notes (the “Notes”) rated A(sf) by Kroll Bond Rating Agency, Inc. (“KBRA”) backed by approximately $357.2 million of senior secured loans. Guggenheim Securities, LLC acted as arranger of the Notes, Wells Fargo Securities, LLC and MUFG Securities Americas Inc. acted as co-managers, and Hercules is the sponsor, originator and
Jan 15, 2019 06:00 am ET
Hercules Capital Announces the Expansion and Appointment of Carol L. Foster to Its Board of Directors
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading and top-tier venture capital firms, today announced that Carol L. Foster was appointed to serve as a member of its board of directors, effec
Jan 14, 2019 10:46 am ET
Hercules Capital Provides US$15M From Existing Facility for Mesoblast to Accelerate Product Commercialization Programs
Mesoblast Limited (ASX: MSB; Nasdaq: MESO) today announced that it has drawn down a further US$15 million from its US$75 million, non-dilutive, four-year credit facility with Hercules Capital, Inc. (NYSE:HTGC). The funds will be used primarily to...
Jan 14, 2019 06:00 am ET
Hercules Capital Renews $125.0 Million Accordion Credit Facility With Initial Commitment of $75.0 Million From Wells Fargo
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) the leading and largest focused specialty finance company to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital and select private equity firms, today announced the renewal of its credit facility with Wells Fargo Capit
Jan 07, 2019 06:00 am ET
Hercules Capital Completes Outstanding Fourth Quarter Originations Activity and Achieves All-Time Record of More Than $1.21 Billion in Total New Debt and Equity Commitments in 2018(1)
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading and largest focused specialty finance company to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital and select private equity firms, today announced its many select investment and operating highlights for
Dec 21, 2018 07:00 am ET
Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan
Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections, today announced the closing of up to a $75 million term loan...
Dec 20, 2018 04:10 pm ET
Hercules’ Debt Investment Portfolio Expected to Generate an Additional $0.04 of Net Investment Income Earnings Annually(2) from the Recent Increase in the Federal Reserve Benchmark Interest Rate
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced the estimated accretive impact to its debt investment portfolio attributed to the Federal Reserve - F
Dec 18, 2018 06:00 am ET
Hercules Capital Announces Share Repurchase Program – Up To $25.0 Million Representing Approximately 2.4% of Common Stock Outstanding(1)
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading and top tier venture capital firms, today announced that its Board of Directors has approved a stock repurchase plan (the “Company 10b5-1 Pl
Dec 11, 2018 03:19 pm ET
Hercules Announces Its Intention to Fully Redeem its 6.25% Notes due 2024
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced its intent to fully redeem approximately $83.5 million (face value) in issued and outstanding aggrega
Dec 06, 2018 12:54 pm ET
Hercules Capital Receives Stockholder Approval to Reduce Its Asset Coverage Requirement to 150%
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that its stockholders approved the proposal to reduce its asset coverage requirement from 200% to 150
Nov 12, 2018 07:55 am ET
Analysis: Positioning to Benefit within Hercules Capital, Teradata, Glu Mobile, Ichor, Amkor Technology, and Energen — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hercules Capital, Inc. (NYSE:HTGC), Teradata Corporation (NYSE:TDC), Glu...
Nov 01, 2018 04:14 pm ET
Hercules Capital Announces Supplemental Cash Distribution of $0.02 per Share for the Third Quarter of 2018
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, is pleased to announce that its Board of Directors has declared a supplemental cash distribution of $0.02 per share.
Nov 01, 2018 04:12 pm ET
Hercules Capital Announces its 53rd Consecutive Quarterly Distribution of $0.31 per Share for the Third Quarter of 2018
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, is pleased to announced that its Board of Directors has declared a third quarter 2018 cash distribution of $0.31 per s
Nov 01, 2018 04:10 pm ET
Hercules Capital Reports Third Quarter 2018 Financial Results
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced its financial results for the third quarter ended September 30, 2018.
Nov 01, 2018 12:51 pm ET
Hercules Capital Completes $200.0 Million Securitization
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced that Hercules Capital Funding Trust 2018-1, a newly-formed wholly owned subsidiary of Hercules, has issued $200.0 million of class A notes (the “Notes”) rated A(sf) by Kroll Bond Rating Agency, Inc. (“KBRA”) backed by approximately $286.0 million of senior secured loans. Guggenheim Securities, LLC acted as arranger of the Notes, and Hercules is the sponsor, originator and servicer for the transaction. The Notes bear interest at a fixed rate of 4.605%. The Notes hav
Oct 17, 2018 06:00 am ET
Hercules Announces Date for Release of Third Quarter 2018 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has scheduled its third quarter 2018 financial results conference call for Thursday, November
Oct 11, 2018 07:45 am ET
Research Report Identifies NIC, Hercules Capital, Natural Health Trends, Hibbett Sports, FleetCor Technologies, and Century Casinos with Renewed Outlook — Fundamental Analysis, Calculating Forward Mov
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NIC Inc. (NASDAQ:EGOV), Hercules Capital, Inc. (NYSE:HTGC), Natural Health...
Sep 28, 2018 06:00 am ET
Hercules’ Debt Investment Portfolio Expected to Generate an Additional $0.04 of Net Investment Income Earnings Annually(2) from the Recent Increase in the Federal Reserve Benchmark Interest Rate
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced the estimated accretive impact to its debt investment portfolio attributed to the Federal Reserve - Fe
Sep 24, 2018 04:10 pm ET
Hercules Capital Closes Public Offering of $40.0 Million 6.25% Notes due 2033
Hercules Capital, Inc. (NYSE:HTGC) (“Hercules” or the “Company”), today announced that it has closed an underwritten public offering of $40.0 million in aggregate principal amount of 6.25% Notes due 2033 (the “Notes”).
Sep 19, 2018 07:13 pm ET
Hercules Capital Prices Public Offering of $40 Million 6.25% Notes due 2033
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has priced an underwritten public offering of $40 million in aggregate principal amount of 6.25% notes due 2033 (the “Notes”). The Notes will mature on October 30, 2033, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after October 30, 2023. The Notes will bear an interest rate of 6.25% per year payable quarterly on January 30, April 30, July 30, and October 30, of each year, beginning October 30, 2018
Sep 10, 2018 06:00 am ET
Hercules Receives BBB Investment Grade Credit and Corporate Rating From DBRS
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that DBRS, Inc. (“DBRS”) has assigned Hercules an investment grade credit and corporate rating of BBB.
Sep 06, 2018 06:00 am ET
Hercules Capital Proudly Receives SBA “Green Light” Letter Approval to Complete its Third SBIC License
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that the U.S. Small Business Administration (“SBA”) has issued a "green light" or "go forth" letter in
Sep 05, 2018 06:00 am ET
Hercules to Seek Stockholder Approval to Reduce Its Asset Coverage Requirement to 150%
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), along with its Board of Directors (the “Board”), has conducted an extensive review of the Small Business Credit Availability Act (“SBCAA”), which passed into law on March 23, 2018. The SBCAA permits Hercules to choose to reduce its asset coverage requirement,
Sep 04, 2018 06:00 am ET
Hercules Capital’s New SaaS Finance Division Has Successfully Originated More Than $305.0 Million in New Debt Commitments YTD 2018
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that its recently formed Hercules Capital SaaS Finance division has surpassed $305.0 million, year-to-
Aug 09, 2018 07:45 am ET
Consolidated Research: 2018 Summary Expectations for HCA Healthcare, The AES, Hercules Capital, Carrizo Oil & Gas, Callon Petroleum, and Ultra Clean — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of HCA Healthcare, Inc. (NYSE:HCA), The AES Corporation (NYSE:AES), Hercules...
Aug 03, 2018 06:00 am ET
Hercules Capital Reaches $8.0 Billion Milestone in Total Debt Commitments Since 2003
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital and private equity firms, today announced that it has originated more than $8.0 billion in total debt commitments since the Company’s incept
Aug 02, 2018 04:10 pm ET
Hercules Capital Announces Second Quarter 2018 Financial Results and Quarterly Distribution of $0.31 per Share
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced its financial results for the second quarter ended June 30, 2018.
Jul 12, 2018 06:00 am ET
Hercules Announces Date for Release of Second Quarter 2018 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has scheduled its second quarter 2018 financial results conference call for Thursday, August 2
Jul 11, 2018 08:55 am ET
Hercules Capital Proudly Announces Eight Portfolio Companies Have Completed or Announced an IPO or M&A Liquidity Event Year-to-Date 2018
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, is pleased to announce the latest liquidity events for eight (8) of its portfolio companies: DocuSign, Inc., Tricida, Inc. and Bridge
Jul 02, 2018 04:15 pm ET
Merrimack Secures $25 Million Debt Facility with Hercules Capital
CAMBRIDGE, Mass., July 2, 2018 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced the closing of a $25 million term loan with Hercules Capital (NYSE: HTGC), $15 million of which was funded at closing today. Merrimack's current cash and cash equivalents, including the $15 million of loan proceeds received, and certain potential net milestone payments anticipated from Shire are projected to fund the company's planned operations into the first quarter of 2020.
Jun 14, 2018 04:10 pm ET
Hercules Capital, Inc. Closes Public Offering of Common Stock Including Option to Purchase Additional Shares
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) today announced that it has closed its underwritten public offering of 6,000,000 shares of its common stock. In addition, the underwriters fully exercised their over-allotment option to purchase 900,000 additional shares of Hercules’ common stock. Today’s closing included the sale of the over-allotment shares, bringing the total number of shares sold in this offering to 6,900,000. The underwriters purchased the shares of common stock from Hercules for a price of $11.78 per share, and net proceeds
Jun 14, 2018 06:30 am ET
Hercules’ Highly Asset Sensitive Debt Investment Portfolio to Generate Additional $0.04 of Net Investment Income Earnings Annually(2) From the Recent Increase in the Federal Reserve Benchmark Interest
Hercules Capital, Inc. (NYSE:HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced the estimated accretive impact to its debt investment portfolio attributed to the Federal Reserve - Fed
Jun 12, 2018 08:57 am ET
Hercules Capital, Inc. Prices Public Offering of Common Stock
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) today announced that it has priced its public offering of 6,000,000 shares of its common stock at a public offering price of $12.15 per share for total gross proceeds of approximately $72.9 million. Hercules has also granted the underwriters an option to purchase up to an additional 900,000 shares of its common stock. The offering is subject to customary closing conditions and is expected to close on June 14, 2018. Wells Fargo Securities, Morgan Stanley, Jefferies LLC, and Keefe, Bruyette & Woods,
Jun 11, 2018 04:06 pm ET
Hercules Capital, Inc. Announces Public Offering of Common Stock
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) today announced that it plans to make a public offering of 6,000,000 shares of its common stock. Hercules also plans to grant the underwriters for the offering an option to purchase up to an additional 900,000 shares of its common stock. Wells Fargo Securities, Morgan Stanley, Jefferies LLC, and Keefe, Bruyette & Woods, A Stifel Company, are acting as joint book-running managers in this offering, and Compass Point is acting as lead manager in this offering.
Jun 11, 2018 06:00 am ET
Hercules Capital on Pace to Potentially Exceed $1.0 Billion in Total New Debt and Equity Commitments in 2018
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading and largest specialty finance company specifically focused on providing growth capital to some of the most innovative and disruptive venture capital backed growth companies in the U.S., many of which are pre-IPO and M&A stage companies backed by so
Jun 08, 2018 03:40 pm ET
Hercules Capital Forms New SaaS Finance Group – Hercules Capital SaaS Finance Division
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced the official launch of the Hercules Capital SaaS Finance division, which will be dedicated exclu
Jun 04, 2018 06:00 am ET
Hercules Increases Its Union Bank Credit Facility to $100.0 Million to Support Investment Portfolio Growth
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced that effective May 25, 2018, it has increased its credit facility with MUFG Union Bank, N.A. (“the Union Bank Credit F
May 10, 2018 06:00 am ET
Hercules Announces Upcoming Events for Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”), the leading specialty financing provider to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that members of the executive management team will be participating at the following events for the financial communi
May 07, 2018 08:25 am ET
Market Trends Toward New Normal in The AES, Immune Pharmaceuticals, Hercules Capital, Zendesk, Chevron, and Cornerstone OnDemand — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The AES Corporation (NYSE:AES), Immune Pharmaceuticals Inc. (NASDAQ:IMNP),...
May 03, 2018 04:10 pm ET
Hercules Capital Announces First Quarter 2018 Financial Results and Quarterly Distribution of $0.31 per Share
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced its financial results for the first quarter ended March 31, 2018.
Apr 30, 2018 06:25 am ET
RumbleOn Announces Closing of $15 Million Senior Secured Credit Facility With Hercules Capital, Inc.
CHARLOTTE, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- RumbleOn, Inc. (NASDAQ:RMBL), a disruptive e-commerce platform facilitating, in one online location, the ability of consumers and dealers to buy, sell, trade, and finance pre-owned vehicles with an emphasis on...
Apr 26, 2018 04:40 pm ET
Hercules Capital Closes Public Offering of $75.0 Million 5.25% Notes Due 2025
Hercules Capital, Inc. (NYSE:HTGC) (“Hercules” or the “Company”), today announced that it has closed an underwritten public offering of $75.0 million in aggregate principal amount of 5.25% notes due 2025 (the “Notes”).
Apr 23, 2018 08:18 pm ET
Hercules Capital Prices Public Offering of $75.0 Million 5.25% Notes due 2025
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has priced an underwritten public offering of $75.0 million in aggregate principal amount of 5.25% notes due 2025 (the “Notes”). The Notes will mature on April 30, 2025, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after April 30, 2021. The Notes will bear an interest rate of 5.25% per year payable quarterly on January 30, April 30, July 30, and October 30, of each year, beginning July 30, 2018. The
Apr 12, 2018 06:00 am ET
Hercules Announces Date for Release of First Quarter 2018 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has scheduled its first quarter 2018 financial results conference call for Thursday, May 3, 20
Apr 10, 2018 01:00 pm ET
Gibraltar Business Capital Welcomes Two New Members to the Business Development Team
CHICAGO, April 10, 2018 /PRNewswire/ -- Gibraltar Business Capital, an industry leader in providing small and mid-market companies with the capital they need to solve short-term challenges or seize growth opportunities, has added two veteran specialty finance lenders to their sales team: Elijah Kaplan and Scott Simmons.
Apr 02, 2018 08:00 am ET
FuelCell Energy Refinances Loan Facility with Hercules Capital
DANBURY, Conn., April 02, 2018 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc.  (Nasdaq:FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, today announced that it entered into...
Mar 22, 2018 06:00 am ET
Hercules’ Highly Asset Sensitive Debt Investment Portfolio to Generate Additional $0.04 of Net Investment Income Earnings Annually(2) from the Recent Increase in the Federal Reserve Benchmark Interest
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced the estimated accretive impact to its debt investment portfolio attributed to the Federal Reserve - Fe
Mar 06, 2018 07:31 pm ET
Mesoblast Enters Into US$75 Million Non-Dilutive Credit Facility
Funds to Advance Commercialization of Cell Therapy for Acute Graft Versus Host Disease and Other Late Stage Product Candidates
Mar 05, 2018 11:17 am ET
Gibraltar Business Capital Joins Hercules Capital as New Portfolio Company
CHICAGO, March 5, 2018 /PRNewswire/ -- Gibraltar Business Capital, an industry leader in providing small and mid-market businesses with the capital they need to solve short-term challenges or seize growth opportunities, has joined Hercules Capital, Inc. (NYSE: HTGC), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms.
Mar 05, 2018 06:55 am ET
Hercules Capital Completes Acquisition of Asset-Based Lender - Gibraltar Business Capital
Hercules Capital, Inc. (NYSE:HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has entered the commercial finance sector through its strategic acquisition of all of the outst
Feb 26, 2018 06:00 am ET
Hercules Announces Upcoming Event for Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that members of the executive management team will be participating at the following event for the f
Feb 22, 2018 04:15 pm ET
Hercules Capital Announces Fourth Quarter and Full-Year 2017 Financial Results and Quarterly Distribution of $0.31 per Share
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced its financial results for the fourth quarter and fiscal-year ended December 31, 2017.
Feb 22, 2018 01:30 pm ET
Hercules Capital, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 22, 2018 / Hercules Capital, Inc. (NYSE: HTGC) will be discussing their earnings results in their Q4 Earnings Call to be held on February 22, 2018 at 5:00 PM Eastern Time.
Feb 20, 2018 04:15 pm ET
Hercules Announces Intention to Partially Redeem its 6.25% Notes Due 2024
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced its intent to redeem approximately $100.0 million (face value) in issued and outstanding aggregate pri
Feb 12, 2018 08:00 am ET
Research Report Identifies Waste Connections, Hercules Capital, Crown, GenMark Diagnostics, Clorox, and Cavium with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Feb. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Waste Connections, Inc. (NYSE:WCN), Hercules Capital,...
Feb 02, 2018 06:00 am ET
Hercules Capital Announces Tax Reporting Information for Calendar Year 2017
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced the 2017 tax treatment for the Company’s common stock distributions (CUSIP #: 427096508).
Feb 01, 2018 06:00 am ET
Hercules Announces Date for Release of Fourth Quarter and Full-Year 2017 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has scheduled its fourth quarter and full-year 2017 financial results conference call for Thur
Jan 09, 2018 06:00 am ET
Hercules Capital Achieves More Than $880 Million in New Commitments in 2017(1)
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced its portfolio update for the fourth quarter and full-year 2017.
Jan 08, 2018 06:00 am ET
Intuity Medical Obtains $70M in Funding From Existing Investors and Hercules Capital
FREMONT, Calif., Jan. 8, 2018 /PRNewswire/ -- Intuity Medical, Inc., a privately-held company developing innovative technologies for diabetes management, announced today that it has closed $42.5M in the initial tranche of a $70M total round of funding which includes $40M in equity financing from Intuity's existing investors, including Accuitive Medical Ventures, Investor Growth Capital, KCK Group, affiliates of Luther King Capital Management, PTV Healthcare Capital, U.S. Venture Partners and Versant Ventures, plus $30M in debt financing from Hercules Capital.
Jan 04, 2018 07:05 am ET
ChemoCentryx Secures up to $100 Million in New Capital Commitments
-- ChemoCentryx to Receive $50 Million Milestone from Vifor Pharma for Validation of Conditional Marketing Authorization Application for Avacopan for the Treatment of ANCA Vasculitis --
Dec 14, 2017 06:00 am ET
Hercules Capital’s Highly Asset Sensitive Debt Investment Portfolio to Generate Additional $0.03 of Net Investment Income Earnings Annually(2) from the Recent Increase in the Federal Reserve Benchmark
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced the estimated accretive impact to its debt investment portfolio attributed to the Federal Reserve - Fe
Nov 21, 2017 08:30 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within Waste Connections, Hercules Capital, Scientific Games, GenMark Diagnostics, Clorox, and Cavium — New Research Emphasizes Economic Gr
NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Waste Connections, Inc. (NYSE:WCN), Hercules Capital,...
Nov 15, 2017 02:00 am ET
Motif Bio secures up to US$20 million debt financing
NEW YORK, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company has entered into an agreement for up to US$20 million...
Nov 03, 2017 06:00 am ET
Hercules Announces Upcoming Events for Financial Community
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”), the leading specialty financing provider to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that members of the executive management team will be participating at the following events for the financial communi
Nov 02, 2017 04:10 pm ET
Hercules Announces Third Quarter 2017 Financial Results and Declares a $0.31 per Share Quarterly Distribution
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced its financial results for the third quarter ended September 30, 2017.
Nov 02, 2017 06:00 am ET
Hercules Capital Acquires Venture Lending Portfolio Assets for ~$125.0 Million
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced that it has entered into a definitive asset purchase agreement with Ares Capital Corporation (NASDAQ:A
Oct 26, 2017 06:00 am ET
Hercules Broadens Board of Directors with the Addition of Two Seasoned Executives
Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced the appointments of Brad Koenig, former Head of Global Technology Investment Banking at Goldman Sachs, and Jorge Titi
Oct 24, 2017 06:00 am ET
Hercules Announces Intention to Partially Redeem its 6.25% Notes Due 2024
Hercules Capital, Inc. (NYSE:HTGC) (“Hercules” or the “Company”), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced its intent to redeem approximately $75.0 million (face value) in issued and outstanding aggregate princ

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.